This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Comprehensive analysis of a tryptophan metabolism-related model in the prognostic prediction and immune status for clear cell renal carcinoma
European Journal of Medical Research Open Access 05 January 2024
-
Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity
Journal for ImmunoTherapy of Cancer Open Access 06 February 2019
-
Harnessing the immune system in glioblastoma
British Journal of Cancer Open Access 05 November 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. IDO inhibitors move center stage in immuno-oncology. Nat Biotechnol 33, 321–322 (2015). https://doi.org/10.1038/nbt0415-321
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0415-321
This article is cited by
-
Comprehensive analysis of a tryptophan metabolism-related model in the prognostic prediction and immune status for clear cell renal carcinoma
European Journal of Medical Research (2024)
-
Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity
Journal for ImmunoTherapy of Cancer (2019)
-
Harnessing the immune system in glioblastoma
British Journal of Cancer (2018)
-
Cytokine resurrection: engineered IL-2 ramps up immuno-oncology responses
Nature Biotechnology (2018)
-
Small-Molecule Targets in Tumor Immunotherapy
Natural Products and Bioprospecting (2018)